Xtant Medical Holdings, Inc.
XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31
Reports and events: 545 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1107:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036981 |
| 2026-08-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036979 |
| 2026-08-0716:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036586 |
| 2026-06-2307:00 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001493152-26-029699 |
| 2026-05-1307:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022604 |
| 2026-05-1307:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022600 |
| 2026-04-1309:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016308 |
| 2026-03-3107:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013792 |
| 2026-03-3107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013788 |
| 2026-03-0208:15 ET | 8-K | 8.01 Other events | 0001493152-26-008453 |
| 2026-01-1616:15 ET | 8-K | 8.01 Other events | 0001493152-26-002569 |
| 2025-12-0316:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025963 |
| 2025-11-1016:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021538 |
| 2025-11-1016:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021512 |
| 2025-11-1007:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-021389 |
| 2025-09-1506:28 ET | DEF 14A | Proxy statementPeriod 2025-09-15 | 0001493152-25-013361 |
| 2025-08-1208:50 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023120 |
| 2025-08-1207:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023109 |
| 2025-08-0816:15 ET | 8-K | 8.01 Other events | 0001641172-25-022762 |
| 2025-08-0516:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-074220 |
| 2025-08-0409:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-022002 |
| 2025-07-0808:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018092 |
| 2025-05-1216:52 ET | S-1 | Registration statement | 0001641172-25-009734 |
| 2025-05-1216:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009674 |
| 2025-05-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009664 |
| 2025-04-1716:31 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-036047 |
| 2025-04-1616:55 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-005078 |
| 2025-04-1419:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000391 |
| 2025-04-1107:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-003711 |
| 2025-03-0616:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-009391 |
| 2025-03-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009386 |
| 2024-11-1216:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044764 |
| 2024-11-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044756 |
| 2024-09-1016:12 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000749 |
| 2024-09-0316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034813 |
| 2024-08-0807:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030667 |
| 2024-08-0807:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030663 |
| 2024-08-0807:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030662 |
| 2024-07-2416:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-028920 |
| 2024-06-1007:00 ET | DEF 14A | Proxy statementPeriod 2024-06-10 | 0001493152-24-023268 |
| 2024-05-1516:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019887 |
| 2024-05-1516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019864 |
| 2024-04-0107:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-012145 |
| 2024-04-0107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-012143 |
| 2024-03-0717:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-009247 |
| 2023-11-1416:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-041077 |
| 2023-11-0907:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-039986 |
| 2023-10-2616:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-23-038380 |
| 2023-10-2317:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-038003 |
| 2023-08-1816:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-23-029442 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.